To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

NCT00226512 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

203

Enrollment

OTHER

Sponsor class

Stopped the PI is no longer work at Hadassah

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Campath-1H /ATG

Sponsor

Hadassah Medical Organization

Collaborators

[object Object]